Calendar Hubei Biocause Pharmaceutical Co., Ltd.

Equities

000627

CNE000000F48

End-of-day quote Shenzhen S.E. 03:30:00 26/04/2024 am IST 5-day change 1st Jan Change
2.35 CNY +4.91% Intraday chart for Hubei Biocause Pharmaceutical Co., Ltd. +2.62% -17.25%

Chart calendar Hubei Biocause Pharmaceutical Co., Ltd.

bdbef6c0db535b7644c056f18276400.HpEidsLdfjlAnOeEZhAuh4_iwxLM21rNsfVZ7L6aV3w.Wul7NJ3uPwki7d_CVE9mstmsnCC6kRG035wohI3xOw9z2FBG75lNUg_Yvg~5ea78fc931544413bb08d78b42678a3a

Upcoming events on Hubei Biocause Pharmaceutical Co., Ltd.

30/04/2024 Q4 2023 Earnings Release
30/04/2024 Q1 2024 Earnings Release
02/09/2024 Q2 2024 Earnings Release (Projected)
31/10/2024 Q3 2024 Earnings Release (Projected)
30/04/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Hubei Biocause Pharmaceutical Co., Ltd.

29/01/2024 11:30 am Extraordinary Shareholders Meeting
31/10/2023 Q3 2023 Earnings Release
31/08/2023 Q2 2023 Earnings Release
19/05/2023 11:30 am Annual General Meeting
28/04/2023 Q1 2023 Earnings Release
23/12/2022 11:30 am Extraordinary Shareholders Meeting
29/10/2022 Q3 2022 Earnings Release
30/08/2022 Interim 2022 Earnings Release
23/05/2022 11:30 am Annual General Meeting
30/04/2022 Q1 2022 Earnings Release
30/04/2022 FY 2021 Earnings Release
30/10/2021 Q3 2021 Earnings Release
31/08/2021 Interim 2021 Earnings Release
20/08/2021 11:30 am Extraordinary Shareholders Meeting
21/05/2021 11:30 am Annual General Meeting
30/04/2021 Q1 2021 Earnings Release
30/04/2021 FY 2020 Earnings Release
25/01/2021 11:30 am Extraordinary Shareholders Meeting
31/10/2020 Q3 2020 Earnings Release
25/09/2020 Extraordinary Shareholders Meeting

Past dividends on Hubei Biocause Pharmaceutical Co., Ltd.

30/05/2023 Annual 0.11 CNY
02/06/2022 Annual 0.005 CNY
04/06/2021 Annual 0.01 CNY
20/05/2020 Final Payment 0.1 CNY
26/09/2019 Interim Payment 0.03 CNY
12/10/2018 Interim Payment 0.03 CNY
08/06/2018 Annual 0.01 CNY
21/06/2017 Annual 0.025 CNY
14/04/2016 Annual 0.009534 CNY

Annual results

Fiscal PeriodDecember 2019 2022
Net sales
Released
Forecast
Spread
0,00


0,00


EBITDA
Released
Forecast
Spread
0,00


0,00


EBIT
Released
Forecast
Spread
0,00


0,00


Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00


Net income
Million CNY
Released
Forecast
Spread
1 776


274


EPS
CNY
Released
Forecast
Spread
0,36


0,06


Announcement Date14/04/2014/04/23

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000627 Stock
  4. Calendar Hubei Biocause Pharmaceutical Co., Ltd.